vTv Therapeutics Presents Baseline Characteristics of the Enrolled Subjects in the Elevage Study Suggesting Comparability to the Post-Hoc Diabetes Subgroup of the Phase 3 STEADFAST StudyGlobeNewsWire • 11/04/20
vTv Therapeutics to Present Study Update and Preliminary Data on Baseline Characteristics of Study Participants in Phase 2 Elevage Study Evaluating Azeliragon at 13th Clinical Trials on Alzheimer's Disease (CTAD) Digital EventGlobeNewsWire • 10/29/20
vTv Therapeutics Presents Additional Positive Clinical Study Results Supporting the Safety and Efficacy of TTP399 as Adjunctive Therapy in Patients with Type 1 DiabetesGlobeNewsWire • 09/23/20
vTv Therapeutics Announces Appointment of Edward P. Taibi to its Board of DirectorsGlobeNewsWire • 09/15/20
vTv Therapeutics to Present Additional Clinical Data from the STEADFAST Study of Azeliragon at the Virtual Alzheimer's Association International ConferenceGlobeNewsWire • 07/27/20
vTv Therapeutics Presents Two Late-Breaking Poster Sessions on Simplici-T1 Study at the American Diabetes Association’s Virtual Sessions Supporting the Potential of TTP399 as First-in-Class Oral Adjunctive Therapy for Type 1 Diabetes PatientsGlobeNewsWire • 06/13/20
vTv Therapeutics Changes its 2020 Annual Meeting of Stockholders to Virtual FormatGlobeNewsWire • 05/22/20
Has vTv Therapeutics (VTVT) Outpaced Other Medical Stocks This Year?Zacks Investment Research • 03/12/20
vTv Therapeutics Inc. (VTVT) Shares March Higher, Can It Continue?Zacks Investment Research • 02/24/20
vTv Therapeutics Announces 2019 Fourth Quarter and Full Year Financial Results and Provides Corporate UpdateGlobeNewsWire • 02/20/20
VTV Therapeutics 'Close To The Finish Line' On What FDA, Diabetes Patients Want: An Adjunct Therapy To InsulinBenzinga • 02/19/20
VTv Therapeutics (VTVT) Reports Q3 Loss, Misses Revenue EstimatesZacks Investment Research • 10/30/19
vTv Therapeutics Presents Additional Positive Data from the Phase 2 Simplici-T1 Study in Patients with Type 1 Diabetes at 55th Annual Meeting of the European Association for the Study of DiabetesGlobeNewsWire • 09/18/19
vTv Therapeutics to Present Posters at Two Scientific Conferences in SeptemberGlobeNewsWire • 09/11/19
vTv Therapeutics to Present at the H.C. Wainwright 21st Annual Global Investment ConferenceGlobeNewsWire • 09/04/19